M V N L Chaitanya, Deepshikha Patle, Sachin Kumar Singh, Avijit Mazumder, Rakesh Kumar Sindhu, Kamal Dua, Navneet Khurana, Prince Arora
{"title":"红景天苷和炎症相关疾病:药理作用和机制靶点的综合见解。","authors":"M V N L Chaitanya, Deepshikha Patle, Sachin Kumar Singh, Avijit Mazumder, Rakesh Kumar Sindhu, Kamal Dua, Navneet Khurana, Prince Arora","doi":"10.1007/s10787-025-01964-y","DOIUrl":null,"url":null,"abstract":"<p><p>Salidroside (SAL), a phenylpropanoid glycoside found in Rhodiola rosea L. roots, is one of the plant's most essential active components. Few studies have shown that it has many health advantages, particularly because it helps combat inflammation, prevent cell death, and protect cells from harm. Research indicated that SAL may protect cardiac myocytes from oxidative stress and enhance glucose uptake in skeletal muscle cells. It also significantly enhanced mitochondrial activity and prevented cell death in pheochromocytoma cells, SH-SY5Y neuroblastoma cells, and cardiomyocytes. Besides its advantages for cellular function, SAL is recognised for its protective effects on the heart and brain. Animal studies have shown efficacy in reducing lung damage induced by LPS and sepsis resulting from caecal ligation and puncture in murine models. SAL seems to enhance insulin resistance via activating a route that links mitochondria to AMPK, PI3K, Akt, and GSK-3β. Aqueous preparations of Rhodiola rosea have shown metabolic benefits by reducing blood glucose levels in streptozotocin-treated diabetic rats, an effect that is negated upon adrenal gland removal. The extensive array of pharmacological effects underscores the considerable therapeutic potential of SAL. Despite the well-documented advantages of SAL, research gaps persist regarding optimal dose, long-term safety, and comprehensive effectiveness comparisons in clinical environments. To assist researchers and clinicians in the biomedical sector in filling in the gaps in their knowledge and gaining a comprehensive picture of SAL's therapeutic applications and mechanisms, this review compiles the numerous results on these topics. It aims to simplify complicated material and highlight areas that need more investigation by integrating our present knowledge of SALs and their sources, biosynthesis, extraction, analysis, pharmacological effects, and molecular processes.</p>","PeriodicalId":13551,"journal":{"name":"Inflammopharmacology","volume":" ","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Salidroside and inflammation-linked disorders: integrative insights into the pharmacological effects and mechanistic targets.\",\"authors\":\"M V N L Chaitanya, Deepshikha Patle, Sachin Kumar Singh, Avijit Mazumder, Rakesh Kumar Sindhu, Kamal Dua, Navneet Khurana, Prince Arora\",\"doi\":\"10.1007/s10787-025-01964-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Salidroside (SAL), a phenylpropanoid glycoside found in Rhodiola rosea L. roots, is one of the plant's most essential active components. Few studies have shown that it has many health advantages, particularly because it helps combat inflammation, prevent cell death, and protect cells from harm. Research indicated that SAL may protect cardiac myocytes from oxidative stress and enhance glucose uptake in skeletal muscle cells. It also significantly enhanced mitochondrial activity and prevented cell death in pheochromocytoma cells, SH-SY5Y neuroblastoma cells, and cardiomyocytes. Besides its advantages for cellular function, SAL is recognised for its protective effects on the heart and brain. Animal studies have shown efficacy in reducing lung damage induced by LPS and sepsis resulting from caecal ligation and puncture in murine models. SAL seems to enhance insulin resistance via activating a route that links mitochondria to AMPK, PI3K, Akt, and GSK-3β. Aqueous preparations of Rhodiola rosea have shown metabolic benefits by reducing blood glucose levels in streptozotocin-treated diabetic rats, an effect that is negated upon adrenal gland removal. The extensive array of pharmacological effects underscores the considerable therapeutic potential of SAL. Despite the well-documented advantages of SAL, research gaps persist regarding optimal dose, long-term safety, and comprehensive effectiveness comparisons in clinical environments. To assist researchers and clinicians in the biomedical sector in filling in the gaps in their knowledge and gaining a comprehensive picture of SAL's therapeutic applications and mechanisms, this review compiles the numerous results on these topics. It aims to simplify complicated material and highlight areas that need more investigation by integrating our present knowledge of SALs and their sources, biosynthesis, extraction, analysis, pharmacological effects, and molecular processes.</p>\",\"PeriodicalId\":13551,\"journal\":{\"name\":\"Inflammopharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-09-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Inflammopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10787-025-01964-y\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10787-025-01964-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Salidroside and inflammation-linked disorders: integrative insights into the pharmacological effects and mechanistic targets.
Salidroside (SAL), a phenylpropanoid glycoside found in Rhodiola rosea L. roots, is one of the plant's most essential active components. Few studies have shown that it has many health advantages, particularly because it helps combat inflammation, prevent cell death, and protect cells from harm. Research indicated that SAL may protect cardiac myocytes from oxidative stress and enhance glucose uptake in skeletal muscle cells. It also significantly enhanced mitochondrial activity and prevented cell death in pheochromocytoma cells, SH-SY5Y neuroblastoma cells, and cardiomyocytes. Besides its advantages for cellular function, SAL is recognised for its protective effects on the heart and brain. Animal studies have shown efficacy in reducing lung damage induced by LPS and sepsis resulting from caecal ligation and puncture in murine models. SAL seems to enhance insulin resistance via activating a route that links mitochondria to AMPK, PI3K, Akt, and GSK-3β. Aqueous preparations of Rhodiola rosea have shown metabolic benefits by reducing blood glucose levels in streptozotocin-treated diabetic rats, an effect that is negated upon adrenal gland removal. The extensive array of pharmacological effects underscores the considerable therapeutic potential of SAL. Despite the well-documented advantages of SAL, research gaps persist regarding optimal dose, long-term safety, and comprehensive effectiveness comparisons in clinical environments. To assist researchers and clinicians in the biomedical sector in filling in the gaps in their knowledge and gaining a comprehensive picture of SAL's therapeutic applications and mechanisms, this review compiles the numerous results on these topics. It aims to simplify complicated material and highlight areas that need more investigation by integrating our present knowledge of SALs and their sources, biosynthesis, extraction, analysis, pharmacological effects, and molecular processes.
期刊介绍:
Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn''s disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:
-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states
-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs
-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents
-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain
-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs
-Muscle-immune interactions during inflammation [...]